- ADePT
A process for Decision-making after Pilot and feasibility Trials
- AI
artificial intelligence
- BP
blood pressure
- CBA
cost–benefit analysis
- CCA
cost–consequence analysis
- CEA
cost-effectiveness analysis
- CMA
cost-minimisation analysis
- COVID-19
coronavirus disease discovered in 2019
- COAG
chronic open-angle glaucoma
- CUA
cost–utility analysis
- DCE
discrete choice experiment
- DHI
digital health intervention
- DHT
digital home monitoring technologies
- GAT
Goldmann applanation tonometer
- HES
hospital eye services
- HRQoL
health-related quality of life
- HTA
Health Technology Assessment
- ICER
incremental cost-effectiveness ratio
- IOP
intraocular pressure
- IQR
interquartile range
- IT
information technology
- I-TRAC
In-home Tracking of glaucoma: Reliability, Acceptability, and Cost
- MD
mean deviation
- MHRA
Medicines and Healthcare Products Regulatory Agency
- MMDT
Moorfields motion displacement test
- MRF
Melbourne Rapid Field
- NICE
National Institute for Health and Care Excellence
- NIHR
National Institute for Health and Care Research
- NTG
normal tension glaucoma
- OAG
open-angle glaucoma
- OHT
ocular hypertension
- PI
principal investigator
- PICO
population, intervention, comparator, outcome
- POAG
primary open-angle glaucoma
- PRISMA
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- QALY
quality-adjusted life-year
- QoL
quality of life
- R&D
research and development
- RCT
randomised controlled trial
- RPM
remote patient monitoring
- SD
standard deviation
- SSC
Study Steering Committee
- TDF
Theoretical Domains Framework
- TFA
Theoretical Framework of Acceptability
- UKCA
UK Conformity Assessed
- UKEGS
UK and Eire Glaucoma Society
- VF
visual field
- WTP
willingness-to-pay
